| Bid Price | 70.00p | High Price | 78.00p |
|---|
| Ask Price | 78.00p | Low Price | 77.40p |
|---|
| Open Price | 74.00p | Spread | 10.26% |
|---|
| Prev Close | 74.00p | Volume | 11,876 |
|---|
Arecor Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 5, 2025 | 74.00 | 78.00 | 77.40 | 74.00 | 11,876 |
| Dec 4, 2025 | 74.00 | 77.60 | 76.44 | 74.00 | 10,979 |
| Dec 3, 2025 | 72.50 | 76.44 | 70.00 | 74.00 | 16,988 |
| Dec 2, 2025 | 72.50 | 75.00 | 70.00 | 72.50 | 15,467 |
| Dec 1, 2025 | 72.50 | 71.83 | 71.83 | 72.50 | 6,956 |
Arecor Therapeutics PLC Information
| Name | Arecor Therapeutics PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BMWLM973 | Epic | AREC |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 1,000 | Trading Status | Closed |
|---|
| Shares in Issue | 37.76 m | Prev Close | 74.00p |
|---|
| PE Ratio | | Market Cap | £27.94 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.07 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.586933 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.051591 | Quick Ratio | 1.83061 |
|---|
Arecor Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 21/05/25 | BUY | Andrew Richards | CH | 31,750 @ £0.47 | £14,913.00 |
| 21/05/25 | BUY | Sarah Howell | CEO | 21,077 @ £0.47 | £9,900.00 |
| 14/05/25 | BUY | Andrew Richards | CH | 35,000 @ £0.41 | £14,438.00 |
| 09/08/24 | PLAC | Alan Smith | RES | 22,222 @ £0.90 | £20,000.00 |
| 09/08/24 | PLAC | Andrew Richards | CH | 27,777 @ £0.90 | £24,999.00 |
| 09/08/24 | PLAC | Mohammad Fazeli | NED | 27,777 @ £0.90 | £24,999.00 |
| 09/08/24 | PLAC | Sarah Howell | CEO | 16,666 @ £0.90 | £14,999.00 |
| 08/11/22 | EXR | Sarah Howell | CEO | 20,666 @ £0.01 | £207.00 |
| 08/11/22 | EXR | Susan Lowther | RES | 62,000 @ £0.01 | £620.00 |
| 04/08/22 | PLAC | Christine Soden | RES | 6,667 @ £3.00 | £20,001.00 |
Arecor Therapeutics PLC News
